- Home
- JGH vs LFCR Comparison
JGH vs LFCR Comparison
Compare JGH & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JGH | LFCR |
|---|---|---|
| Founded | 2014 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 294.5M | 256.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | JGH | LFCR |
|---|---|---|
| Price | $12.55 | $7.82 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 73.9K | ★ 153.9K |
| Earning Date | 01-01-0001 | 01-02-2026 |
| Dividend Yield | ★ 9.85% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $128,867,000.00 |
| Revenue This Year | N/A | $4.72 |
| Revenue Next Year | N/A | $10.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 0.47 |
| 52 Week Low | $10.36 | $4.76 |
| 52 Week High | $12.85 | $8.85 |
Technical Indicators
Market Signals| Indicator | JGH | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 39.71 | 59.33 |
| Support Level | $12.40 | $7.28 |
| Resistance Level | $12.52 | $7.96 |
| Average True Range (ATR) | 0.13 | 0.40 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 39.22 | 65.06 |
Price Performance
Historical ComparisonAbout JGH Nuveen Global High Income Fund of Beneficial Interest
Nuveen Global High Income Fund operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of current income. Its securities include U.S. high-yield bonds; non-U.S. high-yield bonds from developed and emerging markets; and other income-producing investments such as preferred and convertible securities.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.